Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| GeneDx Holdings Corp. | 717 | reported | 01 Jun 2026 | tx 244+6,644,859−675,388 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Jun 2026 | EXERCISE | GeneDx Holdings Corp. | 717 | 0.00 USD | |
| 01 Jun 2026 | SALE | GeneDx Holdings Corp. | 369 | 51.74 USD | |
| 01 Jun 2026 | EXERCISE | GeneDx Holdings Corp. | 717 | 0.00 USD | deriv |
| 26 Mar 2026 | SALE | GeneDx Holdings Corp. | 961 | 62.33 USD | |
| 26 Mar 2026 | SALE | GeneDx Holdings Corp. | 1,857 | 65.21 USD | |
| 26 Mar 2026 | SALE | GeneDx Holdings Corp. | 995 | 64.60 USD | |
| 26 Mar 2026 | SALE | GeneDx Holdings Corp. | 2,520 | 63.28 USD | |
| 26 Mar 2026 | SALE | GeneDx Holdings Corp. | 2,485 | 61.29 USD | |
| 26 Mar 2026 | EXERCISE | GeneDx Holdings Corp. | 16,250 | 0.00 USD | |
| 26 Mar 2026 | EXERCISE | GeneDx Holdings Corp. | 16,250 | 0.00 USD | deriv |
| 16 Mar 2026 | SALE | GeneDx Holdings Corp. | 257 | 77.94 USD | |
| 15 Mar 2026 | EXERCISE | GeneDx Holdings Corp. | 3,815 | 0.00 USD | |
| 16 Mar 2026 | EXERCISE | GeneDx Holdings Corp. | 7,197 | 0.00 USD | |
| 16 Mar 2026 | SALE | GeneDx Holdings Corp. | 3,065 | 77.05 USD | |
| 16 Mar 2026 | SALE | GeneDx Holdings Corp. | 2,384 | 76.35 USD | |
| 15 Mar 2026 | EXERCISE | GeneDx Holdings Corp. | 3,815 | 0.00 USD | deriv |
| 16 Mar 2026 | EXERCISE | GeneDx Holdings Corp. | 7,197 | 0.00 USD | deriv |
| 09 Mar 2026 | SALE | GeneDx Holdings Corp. | 1,280 | 86.75 USD | |
| 09 Mar 2026 | EXERCISE | GeneDx Holdings Corp. | 2,462 | 0.00 USD | |
| 09 Mar 2026 | EXERCISE | GeneDx Holdings Corp. | 2,462 | 0.00 USD | deriv |
| 06 Mar 2026 | GRANT_AWARD | GeneDx Holdings Corp. | 1,986 | 88.11 USD | |
| 03 Mar 2026 | GRANT_AWARD | GeneDx Holdings Corp. | 15,262 | 0.00 USD | |
| 04 Mar 2026 | SALE | GeneDx Holdings Corp. | 2,543 | 78.61 USD | |
| 04 Mar 2026 | SALE | GeneDx Holdings Corp. | 2,220 | 79.25 USD | |
| 04 Mar 2026 | SALE | GeneDx Holdings Corp. | 1,424 | 77.63 USD |